A

Antiverse

15 employees

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Artificial Intelligence
Antibodies
Drug discovery
Machine Learning
Life Science

Date founded

2017

Funding rounds raised

Total raised

$2.8M

from 17 investors over 17 rounds

A

Antiverse raised $2.8M on October 1, 2022

Investors: Development Bank of Wales, AngelHub, Kadmos Capital Ltd, Deep Science Ventures, Tensor Ventures and Innospark Ventures

A

Antiverse raised $1.9M on March 15, 2021

Investors: Wren Capital LLP, Future Planet Capital, ACF Investors, Tensor Ventures, UK Innovation & Science Seed Fund, Development Bank of Wales and Cambridge Angels

A

Antiverse raised undisclosed on January 1, 2020

Investors: Future Planet Capital

A

Antiverse raised $263K on August 1, 2018

Investors: UK Innovation & Science Seed Fund and Future Planet Capital

A

Antiverse raised $26K on July 12, 2018

Investors: Babraham Bioscience Technologies Ltd

FAQ